Hand eczema is a common disease which often gives a chronic course thus affecting many functions in daily life. The body of evidence related to self-management of chronic hand eczema is poor. Better methods to support self-management of patients with chronic hand eczema may potentially improve the prognosis of a disease which is both a tremendous burden to the individual and to the society. The purpose of this trial is to evaluate the effect of a newly designed guidance programme offering individual counselling compared to conventional information with written information sheets.
Detailed description of the trial and the intervention can be found in the publication: Mollerup A, Veien NK, Johansen JD. Chronic hand eczema--self-management and prognosis: a study protocol for a randomised clinical trial'. BMC Dermatol. 2012 Jun 12;12:6. doi: 10.1186/1471-5945-12-6. PMID: 22691871 \[PubMed - indexed for MEDLINE\] Free PMC Article
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
306
The intervention is founded upon three concurrent elements. Firstly, a SKIN-profile generated by data from a baseline questionnaire (S=Susceptibility, K=Competencies, I=Individual characteristics, N=Necessary precautions). Secondly, a patient self-management book which includes a patient's log and is offered in both an online and a physical form. Also support to self-management is offered through possible asynchronous communication and networking. Finally, a counselling consultation with a nurse, trained within dermatology.
Dermatologic practise, Vesterbro 99
Aalborg, Denmark
Department of Dermato-Allergology, Copenhagen University Hospital Gentofte
Hellerup, Denmark
Hand Eczema Severity Index (HECSI)
Objective assessment of disease severity, measured by HECSI-score at time = 6 months versus HECSI-score at time = 0.
Time frame: 6 months
Dermatology Life Quality Index (DLQI)
DLQI measured by questionnaire at time = 6 months versus DLQI measured by questionnaire at time = 0.
Time frame: 6 months
Overall burden of disease (VAS)
VAS measured by questionnaire at time = 6 months versus VAS measured by questionnaire at time = 0.
Time frame: 6 months
Danish version of The Medication Adherence Report Scale (DMARS-4)
DMARS-4 measured by questionnaire at time = 6 months versus DMARS-4 measured by questionnaire at time = 0 months.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.